Answer
Yes, dostarlimab (Jemperli) can cause nephritis, including tubulointerstitial nephritis, which occurred in 3 patients (0.5%), all grade 2, and resolved in all three patients.
Sources for this answer
- JEMPERLI 500 mg concentrate for solution for infusionGlaxoSmithKline UK · emc · SmPC §4.8 Undesirable effects · Version 14Document updated
Sources checked